Lymphoblastoid Cell lines: a Continuous in Vitro Source of Cells to Study Carcinogen Sensitivity and DNA Repair
暂无分享,去创建一个
[1] R. Santella,et al. Removal of benzo(a)pyrene diol epoxide (BPDE)‐DNA adducts as a measure of DNA repair capacity in lymphoblastoid cell lines from sisters discordant for breast cancer , 2002, Environmental and molecular mutagenesis.
[2] G. Speit,et al. Mutagen Sensitivity of Human Lymphoblastoid Cells with a BRCA1 Mutation , 2003, Breast Cancer Research and Treatment.
[3] E. Sturgis,et al. DNA repair in lymphoblastoid cell lines from patients with head and neck cancer. , 1999, Archives of otolaryngology--head & neck surgery.
[4] H. Christiansen,et al. A putatively functional haplotype in the gene encoding transforming growth factor beta-1 as a potential biomarker for radiosensitivity. , 2011, International journal of radiation oncology, biology, physics.
[5] G. Peters,et al. EBNA‐2 and EBNA‐LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein‐Barr virus. , 1994, The EMBO journal.
[6] K. Ory,et al. DNA damage-related gene expression as biomarkers to assess cellular response after gamma irradiation of a human lymphoblastoid cell line , 2000, Oncogene.
[7] I. Demuth,et al. Extreme variation in apoptosis capacity amongst lymphoid cells of Nijmegen breakage syndrome patients. , 2008, European journal of cell biology.
[8] L. Samson,et al. Genomic predictors of interindividual differences in response to DNA damaging agents. , 2008, Genes & development.
[9] S. Bernacki,et al. Characterization of publicly available lymphoblastoid cell lines for disease-associated mutations in 11 genes. , 2005, Clinical chemistry.
[10] E. Kieff,et al. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity , 1988, Journal of virology.
[11] M. Mullendore,et al. Mitochondrial DNA Mutations in Pancreatic Cancer , 2006, International journal of gastrointestinal cancer.
[12] L. Hutt-Fletcher,et al. Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virus , 2002, Nature Medicine.
[13] W. Hammerschmidt,et al. Genetic analysis of immortalizing functions of EpsteinBarr virus in human B lymphocytes , 1989, Nature.
[14] G. Nemerow,et al. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d , 1987, Journal of virology.
[15] I. M. Jones,et al. Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. , 2010, Carcinogenesis.
[16] T. Ide,et al. Steps Involved in Immortalization and Tumorigenesis in Human B-Lymphoblastoid Cell Lines Transformed by Epstein-Barr Virus , 2004, Cancer Research.
[17] T. Carey,et al. Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma. , 2000, Cancer research.
[18] G. Speit,et al. Radiosensitivity of lymphoblastoid cell lines with a heterozygous BRCA1 mutation is not detected by the comet assay and pulsed field gel electrophoresis. , 2005, Mutagenesis.
[19] H. Thierens,et al. The use of EBV-transformed cell lines of breast cancer patients to measure chromosomal radiosensitivity. , 2004, Mutagenesis.
[20] F. Galibert,et al. Cloning and expression of a cDNA for human thioredoxin. , 1988, The Journal of biological chemistry.
[21] D. Kennedy,et al. DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer. , 2005, Journal of the National Cancer Institute.
[22] Richard M Walmsley,et al. Assessment of the genotoxicity of S9-generated metabolites using the GreenScreen HC GADD45a-GFP assay. , 2008, Mutagenesis.
[23] M. Pawlita,et al. Epstein–Barr Virus Nuclear Antigen 2–Estrogen Receptor Fusion Proteins Transactivate Viral and Cellular Genes and Interact with RBP-Jκ in a Conditional Fashion , 1995 .
[24] Z. Talebizadeh,et al. Feasibility and relevance of examining lymphoblastoid cell lines to study role of microRNAs in autism , 2008, Autism research : official journal of the International Society for Autism Research.
[25] B. Kempkes,et al. The Proto-Oncogene c-myc Is a Direct Target Gene of Epstein-Barr Virus Nuclear Antigen 2 , 1999, Journal of Virology.
[26] Joshua T. Herbeck,et al. Fidelity of SNP Array Genotyping Using Epstein Barr Virus-Transformed B-Lymphocyte Cell Lines: Implications for Genome-Wide Association Studies , 2009, PloS one.
[27] L. Young,et al. Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.
[28] M. Filipič,et al. Different sensitivities of human colon adenocarcinoma (CaCo-2), astrocytoma (IPDDC-A2) and lymphoblastoid (NCNC) cell lines to microcystin-LR induced reactive oxygen species and DNA damage. , 2008, Toxicon : official journal of the International Society on Toxinology.
[29] Aldi Kraja,et al. Genome-wide discovery of loci influencing chemotherapy cytotoxicity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[30] P. A. Biro,et al. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[31] U. Vogel,et al. 8-Oxoguanine DNA-glycosylase repair activity and expression: a comparison between cryopreserved isolated lymphocytes and EBV-derived lymphoblastoid cell lines. , 2011, Mutation research.
[32] A. Heck,et al. Human lymphoblastoid proteome analysis reveals a role for the inhibitor of acetyltransferases complex in DNA double-strand break response. , 2006, Cancer research.
[33] D. Watson,et al. Comparison of gene expression changes induced in mouse and human cells treated with direct‐acting mutagens , 2004, Environmental and molecular mutagenesis.
[34] F. Poirier,et al. Proteomic map and database of lymphoblastoid proteins. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[35] P. Farrell. Epstein-Barr virus immortalizing genes. , 1995, Trends in microbiology.
[36] D. Thorley-Lawson,et al. B cell activation and the establishment of Epstein-Barr virus latency , 1988, The Journal of experimental medicine.
[37] D. Kennedy,et al. Double-strand breaks repair in lymphoblastoid cell lines from sisters discordant for breast cancer from the New York site of the BCFR. , 2008, Carcinogenesis.
[38] C. R. Leemans,et al. Microarray Analysis of Bleomycin-Exposed Lymphoblastoid Cells for Identifying Cancer Susceptibility Genes , 2006, Molecular Cancer Research.
[39] T. Toda,et al. Proteome analysis of Epstein-Barr virus-transformed B-lymphoblasts and the proteome database. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[40] M. Pawlita,et al. Epstein-Barr virus nuclear antigen 2-estrogen receptor fusion proteins transactivate viral and cellular genes and interact with RBP-J kappa in a conditional fashion. , 1995, Virology.
[41] E. Kieff,et al. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[42] W. Hammerschmidt,et al. Epstein–Barr virus‐mediated B‐cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor , 1998, The EMBO journal.
[43] T. Dörk,et al. Characterization of ATM gene mutations in 66 ataxia telangiectasia families. , 1999, Human molecular genetics.
[44] Zhifu Sun,et al. Genetic Variation Predicting Cisplatin Cytotoxicity Associated with Overall Survival in Lung Cancer Patients Receiving Platinum-Based Chemotherapy , 2011, Clinical Cancer Research.
[45] L Sie,et al. Utility of lymphoblastoid cell lines , 2009, Journal of neuroscience research.
[46] C. Tyler-Smith,et al. Genetic instability in EBV-transformed lymphoblastoid cell lines. , 2004, Biochimica et biophysica acta.
[47] M. Spitz,et al. DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[48] P. Fortina,et al. Whole-exome sequencing of DNA from peripheral blood mononuclear cells (PBMC) and EBV-transformed lymphocytes from the same donor , 2011, BMC Genomics.
[49] G. Mosialos,et al. Epstein-Barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-κB , 1999, Oncogene.
[50] G. Matullo,et al. Unsuitability of lymphoblastoid cell lines as surrogate of cryopreserved isolated lymphocytes for the analysis of DNA double-strand break repair activity. , 2010, Mutation research.
[51] G. Mosialos,et al. Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB. , 1999, Oncogene.
[52] Heidemarie Neitzel,et al. A routine method for the establishment of permanent growing lymphoblastoid cell lines , 1986, Human Genetics.
[53] A. Iolascon,et al. Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C , 2007, Gut.
[54] M. Desai,et al. Polymorphisms in Nucleotide Excision Repair Genes and DNA Repair Capacity Phenotype in Sisters Discordant for Breast Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.